Caxton Corp

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 12
Total Value: 5080779
Accession Number: 0000919574-25-003127
Form Type: 13F-HR
CIK: 0001388551
Manager Name: Caxton Corp

Data Enrichment

100% identified

12 identified0 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

12 positions • $5,080.779K total value

12 positions

Manager:

SEC FilingSEC DataHachi Filing

Search and click to pin securities to the top

Sort by:

Rezolute, Inc.

Shares:

1318967(+0.0%)

Value:

$3.8B(-40.8%)

SPDR GOLD TRUST

Shares:

1298(+11.0%)

Value:

$374.1M(+32.1%)

BERKSHIRE HATHAWAY INC

BRK-B|084670702

Shares:

467(-58.8%)

Value:

$248.8M(-51.5%)

Mind Medicine (MindMed) Inc.

Shares:

34073(+0.0%)

Value:

$199.3M(-15.9%)

Bicara Therapeutics Inc.

Shares:

10941(+0.0%)

Value:

$142.6M(-25.2%)

Compass Therapeutics, Inc.

Shares:

43465(+0.0%)

Value:

$82.6M(+31.0%)

Lexeo Therapeutics, Inc.

Shares:

17851(+0.0%)

Value:

$61.9M(-47.3%)

Kyverna Therapeutics, Inc.

Shares:

22981(+0.0%)

Value:

$44.4M(-48.4%)

Cardiff Oncology, Inc.

Shares:

13287(+0.0%)

Value:

$41.7M(-27.6%)

Inhibikase Therapeutics, Inc.

Shares:

16393(+0.0%)

Value:

$35.9M(-32.6%)

Adicet Bio, Inc.

Shares:

17488(+0.0%)

Value:

$13.2M(-21.5%)

Context Therapeutics Inc.

Shares:

18403(+0.0%)

Value:

$11.3M(-41.7%)

Instrument	Shares		Other Manager	Value
Rezolute, Inc.(RZLTcusip76200L309)	1.3M	QoQ 0.00% (-0) YoY 0.00% (+0)	All Managers (Combined)	$3.8M	QoQ -40.81% (-$2.6M) YoY +13.72% (+$461.6K)
Spdr Gold Trust(GLDcusip78463V107)	1.3K	QoQ +11.03% (+129) YoY NEW(+1.3K)	All Managers (Combined)	$374.1K	QoQ +32.15% (+$91.0K) YoY NEW(+$374.1K)
Berkshire Hathaway Inc(BRK-Bcusip084670702)	467	QoQ -58.78% (-666) YoY -54.17% (-552)	All Managers (Combined)	$248.8K	QoQ -51.55% (-$264.7K) YoY -41.90% (-$179.5K)
Mind Medicine (Mindmed) Inc.(MNMDcusip60255C885)	34.1K	QoQ 0.00% (-0) YoY +17.23% (-5.0K)	All Managers (Combined)	$199.3K	QoQ -15.94% (-$37.8K) YoY -27.04% (-$73.9K)
Bicara Therapeutics Inc.(BCAXcusip055477103)	10.9K	QoQ 0.00% (-0) YoY NEW(+10.9K)	All Managers (Combined)	$142.6K	QoQ -25.20% (-$48.0K) YoY NEW(+$142.6K)
Compass Therapeutics, Inc.(CMPXcusip20454B104)	43.5K	QoQ 0.00% (+0) YoY 0.00% (-0)	All Managers (Combined)	$82.6K	QoQ +31.03% (+$19.6K) YoY -4.04% (-$3.5K)
Lexeo Therapeutics, Inc.(LXEOcusip52886X107)	17.9K	QoQ 0.00% (-0) YoY +72.99% (-7.5K)	All Managers (Combined)	$61.9K	QoQ -47.26% (-$55.5K) YoY -61.71% (-$99.9K)
Kyverna Therapeutics, Inc.(KYTXcusip501976104)	23.0K	QoQ 0.00% (-0) YoY +45.02% (-7.1K)	All Managers (Combined)	$44.4K	QoQ -48.39% (-$41.6K) YoY -88.73% (-$349.3K)
Cardiff Oncology, Inc.(CRDFcusip14147L108)	13.3K	QoQ 0.00% (-0) YoY NEW(+13.3K)	All Managers (Combined)	$41.7K	QoQ -27.64% (-$15.9K) YoY NEW(+$41.7K)
Inhibikase Therapeutics, Inc.(IKTcusip45719W205)	16.4K	QoQ 0.00% (-0) YoY NEW(+16.4K)	All Managers (Combined)	$35.9K	QoQ -32.61% (-$17.4K) YoY NEW(+$35.9K)
Adicet Bio, Inc.(ACETcusip007002108)	17.5K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$13.2K	QoQ -21.51% (-$3.6K) YoY -67.87% (-$27.9K)
Context Therapeutics Inc.(CNTXcusip21077P108)	18.4K	QoQ 0.00% (-0) YoY NEW(+18.4K)	All Managers (Combined)	$11.3K	QoQ -41.71% (-$8.1K) YoY NEW(+$11.3K)